List of Aricept drug patents
Aricept is owned by Eisai Inc.
Aricept contains Donepezil Hydrochloride.
Aricept has a total of 1 drug patent out of which 0 drug patents have expired.
Aricept was authorised for market use on 23 July, 2010.
Aricept is available in tablet;oral dosage forms.
The generics of Aricept are possible to be released after 04 October, 2026.
| Patent Number | Company | Patent Title | Patent Expiry | Activity Alert |
|---|---|---|---|---|
| These patents focus on the other aspects of the active substance like dosage, mode of administration (oral, tablet, capsules, liquids etc). | ||||
| US8481565 | EISAI INC | Method for stabilizing anti-dementia drug |
Oct, 2026
(3 years from now) | |
Drugs and Companies using DONEPEZIL HYDROCHLORIDE ingredient
Market Authorisation Date: 23 July, 2010
Treatment: NA
Dosage: TABLET;ORAL
How can I launch a generic of ARICEPT before it's patent expiration?
More Information on Dosage
availability in other generic markets.
Click on the highlighted region to filter.
900+ leading pharmaceutical companies are staying up-to-date with drug patents through Pharsight
Join them to stay ahead in capturing the next drug going generic